Senhwa Biosciences, Inc. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was TWD 0.25 million compared to TWD 0.15 million a year ago. Net loss was TWD 97.59 million compared to TWD 68.22 million a year ago. Basic loss per share from continuing operations was TWD 1.09 compared to TWD 0.76 a year ago. Diluted loss per share from continuing operations was TWD 1.09 compared to TWD 0.76 a year ago.
For the six months, sales was TWD 0.5 million compared to TWD 0.3 million a year ago. Net loss was TWD 175.22 million compared to TWD 159.56 million a year ago. Basic loss per share from continuing operations was TWD 1.96 compared to TWD 1.78 a year ago. Diluted loss per share from continuing operations was TWD 1.96 compared to TWD 1.78 a year ago.